Global transcriptional repression by the coactivator SRC-1 mediates disease progression in treatment-resistant breast cancer

被引：0
|
作者：
Ward, E.
Vareslija, D.
Fagan, A.
Hill, A.
Young, L.
机构：
[1] Royal Coll Surg, Dublin, Ireland
[2] Beaumont Hosp, Beaumont, TX USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P3-04-17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-04-17
引用
收藏
页数：1
相关论文
共 41 条
  • [21] Global Characterization of the SRC-1 Transcriptome Identifies ADAM22 as an ER-Independent Mediator of Endocrine-Resistant Breast Cancer
    McCartan, Damian
    Bolger, Jarlath C.
    Fagan, Ailis
    Byrne, Christopher
    Hao, Yuan
    Qin, Li
    McIlroy, Marie
    Xu, Jianming
    Hill, Arnold D.
    Gaora, Peadar O.
    Young, Leonie S.
    CANCER RESEARCH, 2012, 72 (01) : 220 - 229
  • [22] Inverse relationship between ER-β and SRC-1 predicts outcome in endocrine-resistant breast cancer
    E Myers
    F J Fleming
    T B Crotty
    G Kelly
    E W McDermott
    N J O'Higgins
    A D K Hill
    L S Young
    British Journal of Cancer, 2004, 91 : 1687 - 1693
  • [23] Inverse relationship between ER-β and SRC-1 predicts outcome in endocrine-resistant breast cancer
    Myers, E
    Fleming, FJ
    Crotty, TB
    Kelly, G
    McDermott, EW
    O'Higgins, NJ
    Hill, ADK
    Young, LS
    BRITISH JOURNAL OF CANCER, 2004, 91 (09) : 1687 - 1693
  • [24] Interaction of Developmental Transcription Factor HOXC11 with Steroid Receptor Coactivator SRC-1 Mediates Resistance to Endocrine Therapy in Breast Cancer (vol 70, pg 1585, 2010)
    McIlroy, M.
    CANCER RESEARCH, 2010, 70 (08) : 3413 - 3413
  • [25] Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer
    Alacoque L. Browne
    Sara Charmsaz
    Damir Varešlija
    Ailis Fagan
    Nicola Cosgrove
    Sinéad Cocchiglia
    Siobhan Purcell
    Elspeth Ward
    Fiona Bane
    Lance Hudson
    Arnold D. Hill
    Jason S. Carroll
    Aisling M. Redmond
    Leonie S. Young
    Oncogene, 2018, 37 : 2008 - 2021
  • [26] SRC-1 Expression Is a Prognostic Factor of Breast Cancer-Specific and Disease-Free Survival in Inflammatory Breast Cancer.
    Arias-Pulido, H.
    Ahmed, R. D.
    Chaher, N.
    Vargas, J.
    Joste, N.
    Lomo, L.
    Qualls, C.
    Azziez, S.
    Terki, N.
    Bouzid, K.
    Prossnitz, E.
    Royce, M.
    CANCER RESEARCH, 2011, 71
  • [27] Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer
    Browne, Alacoque L.
    Charmsaz, Sara
    Vareslija, Damir
    Fagan, Ailis
    Cosgrove, Nicola
    Cocchiglia, Sinead
    Purcell, Siobhan
    Ward, Elspeth
    Bane, Fiona
    Hudson, Lance
    Hill, Arnold D.
    Carroll, Jason S.
    Redmond, Aisling M.
    Young, Leonie S.
    ONCOGENE, 2018, 37 (15) : 2008 - 2021
  • [28] Coassociation of ERα and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence
    Redmond, A. M.
    Bane, F. T.
    Stafford, A. T.
    McIlroy
    Dillon, M. F.
    Hill, A. D. K.
    Young, L. S.
    CANCER RESEARCH, 2009, 69 (02) : 214S - 214S
  • [29] Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence
    Redmond, Aisling M.
    Bane, Fiona T.
    Stafford, T.
    Mcllroy, Marie
    Dillon, Mary F.
    Crotty, Thomas B.
    Hill, Arnold D.
    Young, Leonie S.
    CLINICAL CANCER RESEARCH, 2009, 15 (06) : 2098 - 2106
  • [30] The Role of the Steroid Receptor Coactivator SRC1 and Its Functional Partner HOXC11 in the Development of Endocrine Resistant Breast Cancer.
    Walsh, C. A.
    McCartan, D.
    Hill, A. D. K.
    Young, L. S.
    CANCER RESEARCH, 2011, 71
12345